Yüklüyor......
The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
Background: There is conflicting data about the increased risk of pulmonary toxicity when granulocyte-stimulating factor (G-CSF) is given in combination with bleomycin. No clear consensus for management of patients with Hodgkin lymphoma (HL) who require G-CSF support exists. Our objective was to eva...
Kaydedildi:
| Yayımlandı: | Int J Hematol Oncol Stem Cell Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5767288/ https://ncbi.nlm.nih.gov/pubmed/29340124 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|